Modern Corporate Risk Management: A Blueprint for Positive Change and Effectiveness - Hardcover

21st century companies are constantly evaluating and re-evaluating the risk inherent to their businesses. Many firms have instituted risk management programs to plan for and better protect key investments and risk-related change management initiatives to execute change in the organization. This implementation, however, can be difficult due to its complexity and because many areas of the firm can be resistant to change. Modern Corporate Risk Management offers forward-thinking, practical solutions to the technical, organizational, cultural, and political problems related to corporate portfolio risk management, including how to realize the related changes needed in most corporations to become effective. Written in an easy-to-understand format by an expert who has worked in a broad spectrum of businesses and industries, this book explores using probabilistic techniques for budget/portfolio processes and estimating project value, implementing external verification and ""assembly line"" processes, promoting holistic thinking, and encouraging cross-silo interactions. This valuable reference is for anyone who has responsibility for managing enterprise or project management risk.

Glenn Koller is a Senior Advisor for Risk Evaluation at BP with responsibilities including implementation of risk-assessment and risk-management technologies and processes in the corporation, development of statistical routines that comprise corporate risk systems, marketing risk technology, and performing technical and consulting services. His experience includes portfolio management, business and product development, managing environmental concerns, ranking and prioritization of projects and products, analysis of legal scenarios, and other aspects of the corporation's diversified business. Mr. Koller has authored three books on risk/uncertainty, holds two U.S. and international patents, is a sought-after keynote speaker at risk-related conferences, and is a technical advisor to the pharmaceutical industry. He received his Ph.D. in geochemistry/geophysics from Syracuse University.